A Review of First-Line Treatment for Small-cell Lung Cancer
@article{Murray2006ARO, title={A Review of First-Line Treatment for Small-cell Lung Cancer}, author={N. Murray and A. Turrisi}, journal={Journal of Thoracic Oncology}, year={2006}, volume={1}, pages={270-278} }
Although small-cell lung cancer (SCLC) makes up a smaller proportion of all lung cancers than it did 25 years ago, it remains a common cause of cancer mortality that requires more clinical and basic research than is currently underway. Trials of newer chemotherapy variations have failed to produce a regimen that is clearly superior to the two-drug combination of etoposide and cisplatin, which remains the standard of care for both limited and extensive stage SCLC. Paradoxically, advances in this… CONTINUE READING
Figures and Topics from this paper
Figures
102 Citations
Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
- Medicine
- Drug design, development and therapy
- 2013
- 4
- PDF
Novel systemic therapies for small cell lung cancer.
- Medicine
- Journal of the National Comprehensive Cancer Network : JNCCN
- 2008
- 28
- PDF
[Analysis of Efficacy of Surgical Treatment for IIIa Small Cell Lung Cancer].
- Medicine
- Zhongguo fei ai za zhi = Chinese journal of lung cancer
- 2017
- 1
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
- Medicine
- OncoTargets and therapy
- 2013
- 10
- PDF
References
SHOWING 1-10 OF 77 REFERENCES
Influence of age on the treatment of limited-stage small-cell lung cancer.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 1996
- 141
Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.
- Medicine
- Journal of the National Cancer Institute
- 1997
- 182
- PDF
Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung.
- Medicine
- The New England journal of medicine
- 1987
- 437
Radiation dose intensification in limited-stage small-cell lung cancer.
- Medicine
- Clinical lung cancer
- 2003
- 2
Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 1994
- 96
Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 1991
- 138
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 1993
- 628
Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2001
- 263
Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 1997
- 155